Latest filing published 09 Dec 2021 for 同和药业, €1.9M.
Filing timeline
BuySaleInsider track record
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +32.8%Entry CN¥12.19 · Close at T+365 CN¥16.18
- +31.4%Entry CN¥12.20 · Close at T+365 CN¥16.03
- +30.7%Entry CN¥12.05 · Close at T+365 CN¥15.75
- +14.9%Entry CN¥9.99 · Close at T+365 CN¥11.48
- +10.1%Entry CN¥10.43 · Close at T+365 CN¥11.48
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
梁忠诚: trading record in brief
This profile gathers the share dealings of 梁忠诚 in 同和药业, where the filings describe the role as senior executive. The record holds 5 filings, for trades running from 23 September 2021 to 9 December 2021.
No open-market sale appears; the market trades are 5 purchases worth €3.9M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket.
A typical purchase (the median) is worth €855k. 5 out of 5 purchases came within 30 days of a purchase by at least one other insider of the same company. Such overlaps are known as a cluster signal: distinct people reaching the same decision at about the same time. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +19.9%. Past outcomes like these are no guarantee of what comes next.
On 9 December 2021 came the latest disclosure, an open-market purchase for €1.9M in 同和药业. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done. These figures are compiled from regulatory filings published by SSE / SZSE (CSRC). They describe what insiders did and are not a recommendation.
Companies and markets linked to 梁忠诚
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 723,800 shares47.5% of flowA股XSHESZSE:173000005346049100Canonical exit: 9 Mar 2022 (T+90)
- 341,900 shares21.9% of flowA股XSHESZSE:173000005150958140Canonical exit: 8 Mar 2022 (T+90)
- 87,600 shares5.4% of flowA股XSHESZSE:173000005146928030Canonical exit: 7 Mar 2022 (T+90)
- 423,600 shares22.5% of flowA股XSHESZSE:173000005129698200Canonical exit: 23 Dec 2021 (T+90)
- 50,000 shares2.6% of flowA股XSHESZSE:173000004905057730Canonical exit: 22 Dec 2021 (T+90)
5 of 5 declarations